CellTrans’ Donislecel: Insulin Independence Data May Offer Path To Market In Type 1 Diabetes

Pancreas secreting insulin
Restoration of insulin independence with pancreatic islet cell therapy would remove the risk of hypoglycemia from exogenous insulin. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers